Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Neoplasms 2Lymphoma, Non-Hodgkin 1Febrile Neutropenia 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Levofloxacin × Clear all
NCT03003273 2019-02-01

DALFEN

All India Institute of Medical Sciences

Phase 3 Terminated
142 enrolled
Classical hematology

Neoplasms, Febrile Neutropenia

NCT00250718 2015-08-03

Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach

New Mexico Cancer Research Alliance

Phase 2 Terminated
17 enrolled 4 charts
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡